the annual 2015 financial results conference call is held on the basis of a review of the current status of the acelrx pharmaceuticals ( acx ) product candidates. the meeting is held on march 7, 2016. the meeting is held on the basis of a review on the current status of the acelrna clinical development pathway and the results of the annual annual annual annual annual annual annual annual annual annual report on form 10-q. the meeting will provide information on the process and timing of anticipated future development of acelrna.